1. Home
  2. DNTH vs CARS Comparison

DNTH vs CARS Comparison

Compare DNTH & CARS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DNTH
  • CARS
  • Stock Information
  • Founded
  • DNTH 2015
  • CARS 1998
  • Country
  • DNTH United States
  • CARS United States
  • Employees
  • DNTH N/A
  • CARS N/A
  • Industry
  • DNTH Biotechnology: Pharmaceutical Preparations
  • CARS Motor Vehicles
  • Sector
  • DNTH Health Care
  • CARS Consumer Discretionary
  • Exchange
  • DNTH Nasdaq
  • CARS Nasdaq
  • Market Cap
  • DNTH 651.8M
  • CARS 745.2M
  • IPO Year
  • DNTH N/A
  • CARS 2017
  • Fundamental
  • Price
  • DNTH $20.74
  • CARS $12.63
  • Analyst Decision
  • DNTH Strong Buy
  • CARS Strong Buy
  • Analyst Count
  • DNTH 8
  • CARS 5
  • Target Price
  • DNTH $53.00
  • CARS $17.30
  • AVG Volume (30 Days)
  • DNTH 326.6K
  • CARS 885.9K
  • Earning Date
  • DNTH 08-07-2025
  • CARS 08-07-2025
  • Dividend Yield
  • DNTH N/A
  • CARS N/A
  • EPS Growth
  • DNTH N/A
  • CARS 69.36
  • EPS
  • DNTH N/A
  • CARS 0.63
  • Revenue
  • DNTH $4,854,000.00
  • CARS $717,845,000.00
  • Revenue This Year
  • DNTH N/A
  • CARS $2.68
  • Revenue Next Year
  • DNTH N/A
  • CARS $3.71
  • P/E Ratio
  • DNTH N/A
  • CARS $20.03
  • Revenue Growth
  • DNTH 17.87
  • CARS 0.68
  • 52 Week Low
  • DNTH $13.37
  • CARS $9.56
  • 52 Week High
  • DNTH $32.27
  • CARS $20.47
  • Technical
  • Relative Strength Index (RSI)
  • DNTH 53.56
  • CARS 50.65
  • Support Level
  • DNTH $18.08
  • CARS $12.41
  • Resistance Level
  • DNTH $21.18
  • CARS $13.15
  • Average True Range (ATR)
  • DNTH 1.50
  • CARS 0.60
  • MACD
  • DNTH -0.10
  • CARS -0.07
  • Stochastic Oscillator
  • DNTH 59.38
  • CARS 73.36

About DNTH Dianthus Therapeutics Inc.

Dianthus Therapeutics Inc is a clinical-stage biotechnology company dedicated to designing and delivering novel, monoclonal antibodies with improved selectivity and potency over existing complement therapies. The company is focused on developing next-generation complement therapeutics for patients living with severe autoimmune and inflammatory diseases. The company is comprised of an experienced team of biotech and pharma executives. The company's pipeline consists of DNTH103 a subcutaneous active C1s antibody.

About CARS Cars.com Inc.

Cars.com Inc is an online destination for buying and selling new and used vehicles. It is an audience-driven technology company empowering the automotive industry. The company brands include Dealer Inspire, DealerRater, FUEL, Accu-Trade, PickupTrucks.com, CreditIQ, and NewCars.com., websites directed towards different consumer segments.

Share on Social Networks: